Ad
related to: drugs that increase gi motility in men and prostate disease caused by takingconsumereview.org has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Activation of a wide range of serotonin receptors by serotonin itself or by certain prokinetic drugs results in enhanced gastrointestinal motility. [ 3 ] Other prokinetic drugs may increase acetylcholine concentrations by stimulating the M 1 receptor which causes acetylcholine release, or by inhibiting the enzyme acetylcholinesterase which ...
Cisapride is a gastroprokinetic agent, a drug that increases motility in the upper gastrointestinal tract. It acts directly as a serotonin 5-HT 4 receptor agonist and indirectly as a parasympathomimetic. Stimulation of the serotonin receptors increases acetylcholine release in the enteric nervous system.
Autoimmune gastrointestinal dysmotility (AGID) is an autoimmune disease autonomic neuropathy affecting the gastrointestinal organs and digestive system of the body. Dysmotility is when the strength or coordination of the esophagus , stomach or intestines muscles do not work as they should.
Lubiprostone is a bicyclic fatty acid [15] derived from prostaglandin E1 that acts by specifically activating ClC-2 chloride channels on the apical aspect of gastrointestinal epithelial cells, producing a chloride-rich fluid secretion. These secretions soften the stool, increase motility, and promote spontaneous bowel movements.
The role of the prostate was questioned in the cause of CP/CPPS when both men and women in the general population were tested using the (1) National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI [92]) – with the female homologue of each male anatomical term used on questionnaires for female participants – (2) the ...
Dutasteride, sold under the brand name Avodart among others, is a medication primarily used to treat the symptoms of a benign prostatic hyperplasia (BPH), an enlarged prostate not associated with cancer. A few months may be required before benefits occur. [5] It is also used for scalp hair loss in men and as a part of hormone therapy in ...
In men with prostate cancer, bicalutamide monotherapy has been found to increase the likelihood of death due to causes other than prostate cancer. Bicalutamide has been found to cause unfavorable liver changes in around 3 to 11% of people, with such changes necessitating discontinuation in approximately 1%.
Alpha blockers may increase GI motility if that is an issue, also 5 mg to 10 mg amitriptyline if motility is an issue that can't be solved by other methods Antigas - simethicone , beano , omnimax reduces epigastric pressure
Ad
related to: drugs that increase gi motility in men and prostate disease caused by takingconsumereview.org has been visited by 100K+ users in the past month